MCA
EW icon

Martin Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Martin Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
27,473
+1,247
+5% +$104K 1.3% 18
2026
Q1 		$2.1M Buy
26,226
+150
+0.6% +$12.4K 1.33% 21
2025
Q4 		$2.22M Buy
26,076
+360
+1% +$29.5K 1.3% 20
2025
Q3 		$2M Buy
25,716
+92
+0.4% +$7.19K 1.21% 24
2025
Q2 		$2M Buy
25,624
+700
+3% +$52.2K 1.3% 23
2025
Q1 		$1.81M Sell
24,924
-622
-2% -$44.5K 1.29% 23
2024
Q4 		$1.89M Hold
25,546
– – 1.22% 24
2024
Q3 		$1.69M Buy
25,546
+186
+0.7% +$13.5K 1.2% 24
2024
Q2 		$2.34M Sell
25,360
-130
-0.5% -$11.5K 1.76% 15
2024
Q1 		$2.44M Hold
25,490
– – 1.91% 15
2023
Q4 		$1.94M Buy
25,490
+128
+0.5% +$8.91K 1.64% 19
2023
Q3 		$1.76M Buy
25,362
+880
+4% +$70.7K 1.71% 17
2023
Q2 		$2.31M Buy
24,482
+257
+1% +$22.3K 2.11% 11
2023
Q1 		$2M Sell
24,225
-1,485
-6% -$117K 2.07% 13
2022
Q4 		$1.92M Buy
25,710
+3,401
+15% +$262K 2.14% 13
2022
Q3 		$1.84M Sell
22,309
-17,900
-45% -$1.72M 2.71% 8
2022
Q2 		$3.82M Hold
40,209
– – 3.37% 6
2022
Q1 		$4.73M Buy
40,209
+300
+0.8% +$33.7K 3.24% 7
2021
Q4 		$5.17M Buy
+39,909
New +$4.66M 3.2% 6

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Martin Capital Advisors's EW Position: Q2 2026 in Review

Martin Capital Advisors increased its Edwards Lifesciences (EW) stake by 4.8% in Q2 2026, buying an estimated $104K and bringing the position to 27,473 shares worth $2.49M. The position accounts for 1.3% of the portfolio, ranked #18.

Martin Capital Advisors first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.17M in Q4 2021. 531 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Martin Capital Advisors held 27,473 shares of Edwards Lifesciences worth $2.49M as of Q2 2026.
  • Martin Capital Advisors bought 1,247 Edwards Lifesciences shares in Q2 2026, an estimated $104K.
  • Edwards Lifesciences made up 1.3% of Martin Capital Advisors's portfolio in Q2 2026, its #18 holding.
  • Martin Capital Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Martin Capital Advisors's Edwards Lifesciences position peaked at $5.17M in Q4 2021.
  • 531 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.